References
- Pepys MB, Baltz ML . Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34:141–212.
- Ortega M, Rovira M, Almela M, de la Bellacasa JP, Carreras E, Mensa J . Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation. Bone Marrow Transplant 2004; 33:741–4.
- Arber C, Passweg JR, Fluckiger U, Pless M, Gregor M, Tichelli A, . C-reactive protein and fever in neutropenic patients. Scand J Infect Dis 2000; 32:515–20.
- Yonemori K, Kanda Y, Yamamoto R, Hamaki T, Suguro M, Chizuka A, . Clinical value of serial measurement of serum C-reactive protein level in neutropenic patients. Leuk Lymphoma 2001; 41:607–14.
- Schofield KP, Voulgari F, Gozzard DI, Leyland MJ, Beeching NJ, Stuart J. C-reactive protein concentration as a guide to antibiotic therapy in acute leukaemia. J Clin Pathol 1982; 35:866–9.
- Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973–9.
- Masaoka T. Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary. Clin Infect Dis 2004; 39(Suppl 1):S49–52.
- Drahovsky D, Dunzendorfer U, Ziegenhagen G, Drahovsky M, Kellen JA. Reevaluation of C-reactive protein in cancer sera by radioimmunoassay and radial immunodiffusion. I. Diagnostic value and use in battery of conventional tumor markers. Oncology 1981; 38:286–91.
- Koukourakis MI, Kambouromiti G, Pitsiava D, Tsousou P, Tsiarkatsi M, Kartalis G. Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication. Inflammation 2009; 32:169–75.
- Sandri MT, Passerini R, Leon ME, Peccatori FA, Zorzino L, Salvatici M, . Procalcitonin as a useful marker of infection in hemato-oncological patients with fever. Anticancer Res 2008; 28:3061–5.
- Prat C, Sancho JM, Dominguez J, Xicoy B, Gimenez M, Ferra C, . Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk Lymphoma 2008; 49:1752–61.
- von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P, Hahn C, . Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 2004; 23:539–44.
- Hambach L, Eder M, Dammann E, Schrauder A, Sykora KW, Dieterich C, . Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation. Haematologica 2002; 87:643–51.
- Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 2005; 142:979–95.